MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. (Q40477997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Parth Desai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Pei Lin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

C Cameron Yin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Guilin Tang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Xuan J Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sergej N Konoplev

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Joseph D Khoury

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Carlos E Bueso-Ramos

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

L Jeffrey Medeiros

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

8 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

1090-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

Double-hit B-cell lymphomas

25 February 2020

cites work

1 reference

c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells

21 January 2018

1 reference

The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma

21 January 2018

1 reference

Advances in the understanding of MYC-induced lymphomagenesis

21 January 2018

1 reference

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

21 January 2018

1 reference

Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

21 January 2018

1 reference

BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms

21 January 2018

1 reference

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma

21 January 2018

1 reference

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

21 January 2018

1 reference

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

21 January 2018

1 reference

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.

21 January 2018

1 reference

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

21 January 2018

1 reference

Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations

21 January 2018

1 reference

Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.

21 January 2018

1 reference

MYC/BCL2 double-hit high-grade B-cell lymphoma

21 January 2018

1 reference

Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.

21 January 2018

1 reference

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma

21 January 2018

1 reference

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

21 January 2018

1 reference

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

21 January 2018

1 reference

B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas.

21 January 2018

1 reference

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma

21 January 2018

1 reference

Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.

21 January 2018

1 reference

Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26426741%20AND%20SRC:MED&resulttype=core&format=json